Cognition Therapeutics Announces Publication of Complete Results from Phase 1 Clinical Trial of Elayta™
Press Release
, February 19th, 2019
About: dhartzell@elias-savion.com
Recent Posts by dhartzell@elias-savion.com
Carmell Therapeutics to Present at the 21st Annual BIO CEO & Investor Conference in New York
Press Release
, February 4th, 2019
ALung raises $5M
Pittsburgh Business Times
, January 9th, 2019
Wendy F. DiCicco joins Carmell Therapeutics’ Board of Directors
Press Release
, January 3rd, 2019
Toward a More Robust Regulatory Pathway — 3 Qs with Carmell Therapeutics’ CEO Randy Hubbell
Press Release
, December 26th, 2018
Carmell Therapeutics President & CEO, Randy Hubbell, to Present at Biotech Showcase™ 2019 in San Francisco
Press Release
, December 20th, 2018
ALung Announces Significant Progress in its Hemolung Clinical Trial Programs
Press Release
, December 10th, 2018
Cognition Therapeutics Expands Industry-Leading Expertise in Research and Clinical Use of Biomarkers of Alzheimer’s Disease
Press Release
, November 27th, 2018
President and CEO, Randy Hubbell delivers a corporate presentation at the Investival Showcase at the Waldorf Hilton Hotel in London
Press Release
, November 13th, 2018
Carmell Therapeutics President & CEO, Randy Hubbell, to Present at Investor and MedTech Conferences in November
Press Release
, November 8th, 2018
Recent Comments by dhartzell@elias-savion.com
No comments by dhartzell@elias-savion.com yet.